 ANNUAL REPORT & ACCOUNTS 2017 03
REVENUE OF £21.5 MILLION
(2016: £17.4 million)
Earnings before interest, taxation,
depreciation and amortisation (EBITDA)
£4.8 million
(2016: £3.1 million)
Strong balance sheet with cash and cash equivalents 
of £18.4 million at year end 
(2016: £11.9 million)
ANNUAL REPORT & ACCOUNTS 2017 03
FINANCIAL HIGHLIGHTS:
• Revenue for the period up circa 24% at £21.5 million (2016: £17.4 million)
• EBITDA for the period of £4.8 million (2016: £3.1 million)
• Profit before tax for the period of £4.0 million (2016: £2.8 million)
• Earnings per share of 6.69 pence (2016: 3.99p pence)
• Strong balance sheet with cash and cash equivalents balance up 55% at £18.4 million 
(31 December 2016: £11.9 million)
• Final dividend of 1.2 pence per ordinary share recommended (2016: 1.0 pence)
OPERATIONAL HIGHLIGHTS:
• UK administered International SIPP product launched to compensate for part of the lost 
ROPS market
• Refocus on expansion in UK regulated products but still for expatriate market
• Acquisition of London & Colonial fully integrated and delivering anticipated returns
• Strengthening of the Group’s corporate governance with the new role of Head of Enterprise 
Risk Management
• Bolt on acquisition in Malta
• Life assurance business now a significant Group revenue and profit contributor following 
acquisition and organic growth
